Literature DB >> 25938002

VFMA: Topographic Analysis of Sensitivity Data From Full-Field Static Perimetry.

Richard G Weleber1, Travis B Smith1, Dawn Peters2, Elvira N Chegarnov1, Scott P Gillespie3, Peter J Francis4, Stuart K Gardiner5, Jens Paetzold6, Janko Dietzsch6, Ulrich Schiefer7, Chris A Johnson8.   

Abstract

PURPOSE: To analyze static visual field sensitivity with topographic models of the hill of vision (HOV), and to characterize several visual function indices derived from the HOV volume.
METHODS: A software application, Visual Field Modeling and Analysis (VFMA), was developed for static perimetry data visualization and analysis. Three-dimensional HOV models were generated for 16 healthy subjects and 82 retinitis pigmentosa patients. Volumetric visual function indices, which are measures of quantity and comparable regardless of perimeter test pattern, were investigated. Cross-validation, reliability, and cross-sectional analyses were performed to assess this methodology and compare the volumetric indices to conventional mean sensitivity and mean deviation. Floor effects were evaluated by computer simulation.
RESULTS: Cross-validation yielded an overall R2 of 0.68 and index of agreement of 0.89, which were consistent among subject groups, indicating good accuracy. Volumetric and conventional indices were comparable in terms of test-retest variability and discriminability among subject groups. Simulated floor effects did not negatively impact the repeatability of any index, but large floor changes altered the discriminability for regional volumetric indices.
CONCLUSIONS: VFMA is an effective tool for clinical and research analyses of static perimetry data. Topographic models of the HOV aid the visualization of field defects, and topographically derived indices quantify the magnitude and extent of visual field sensitivity. TRANSLATIONAL RELEVANCE: VFMA assists with the interpretation of visual field data from any perimetric device and any test location pattern. Topographic models and volumetric indices are suitable for diagnosis, monitoring of field loss, patient counseling, and endpoints in therapeutic trials.

Entities:  

Keywords:  clinical trial endpoints; retinitis pigmentosa; standard automated perimetry; visual fields; volumetric measures of the hill of vision

Year:  2015        PMID: 25938002      PMCID: PMC4413926          DOI: 10.1167/tvst.4.2.14

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


  24 in total

1.  The effective dynamic ranges of standard automated perimetry sizes III and V and motion and matrix perimetry.

Authors:  Michael Wall; Kimberly R Woodward; Carrie K Doyle; Gideon Zamba
Journal:  Arch Ophthalmol       Date:  2010-05

2.  Variability in patients with glaucomatous visual field damage is reduced using size V stimuli.

Authors:  M Wall; K E Kutzko; B C Chauhan
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-02       Impact factor: 4.799

3.  Comparison between MP-1 and Humphrey visual field defects in glaucoma and retinitis pigmentosa.

Authors:  Jennifer H Acton; R Theodore Smith; Jonathan P Greenberg; Vivienne C Greenstein
Journal:  Optom Vis Sci       Date:  2012-07       Impact factor: 1.973

4.  Rod visual fields in cone-rod degeneration. Comparisons to retinitis pigmentosa.

Authors:  D G Birch; J L Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-11       Impact factor: 4.799

5.  Disease expression of RP1 mutations causing autosomal dominant retinitis pigmentosa.

Authors:  S G Jacobson; A V Cideciyan; A Iannaccone; R G Weleber; G A Fishman; A M Maguire; L M Affatigato; J Bennett; E A Pierce; M Danciger; D B Farber; E M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

6.  Effect of stimulus size on static visual fields in patients with retinitis pigmentosa.

Authors:  W H Swanson; J Felius; D G Birch
Journal:  Ophthalmology       Date:  2000-10       Impact factor: 12.079

7.  Quantification of glaucomatous visual field defects with automated perimetry.

Authors:  J Flammer; S M Drance; L Augustiny; A Funkhouser
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-02       Impact factor: 4.799

8.  Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.

Authors:  D G Birch; J L Anderson; G E Fish
Journal:  Ophthalmology       Date:  1999-02       Impact factor: 12.079

9.  Normal central retinal function and structure preserved in retinitis pigmentosa.

Authors:  Samuel G Jacobson; Alejandro J Roman; Tomas S Aleman; Alexander Sumaroka; Waldo Herrera; Elizabeth A M Windsor; Lori A Atkinson; Sharon B Schwartz; Janet D Steinberg; Artur V Cideciyan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

10.  Volume of visual field assessed with kinetic perimetry and its application to static perimetry.

Authors:  John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2011-04-26
View more
  27 in total

1.  Mesopic and dark-adapted two-color fundus-controlled perimetry in patients with cuticular, reticular, and soft drusen.

Authors:  Maximilian Pfau; Moritz Lindner; Martin Gliem; Julia S Steinberg; Sarah Thiele; Robert P Finger; Monika Fleckenstein; Frank G Holz; Steffen Schmitz-Valckenberg
Journal:  Eye (Lond)       Date:  2018-08-01       Impact factor: 3.775

2.  Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.

Authors:  Erin A Boese; Nieraj Jain; Yali Jia; Catie L Schlechter; Cary O Harding; Simon S Gao; Rachel C Patel; David Huang; Richard G Weleber; Melanie B Gillingham; Mark E Pennesi
Journal:  Ophthalmology       Date:  2016-08-02       Impact factor: 12.079

3.  Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in CYP4V2.

Authors:  Catherine M Lockhart; Travis B Smith; Paul Yang; Malini Naidu; Allan E Rettie; Abhinav Nath; Richard Weleber; Edward J Kelly
Journal:  Br J Ophthalmol       Date:  2017-07-11       Impact factor: 4.638

4.  Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.

Authors:  David G Birch; Paul S Bernstein; Alessandro Iannacone; Mark E Pennesi; Byron L Lam; John Heckenlively; Karl Csaky; Mary Elizabeth Hartnett; Kevin L Winthrop; Thiran Jayasundera; Dianna K Hughbanks-Wheaton; Judith Warner; Paul Yang; Gary Edd Fish; Michael P Teske; Neal L Sklaver; Laura Erker; Elvira Chegarnov; Travis Smith; Aimee Wahle; Paul C VanVeldhuisen; Jennifer McCormack; Robert Lindblad; Steven Bramer; Stephen Rose; Patricia Zilliox; Peter J Francis; Richard G Weleber
Journal:  JAMA Ophthalmol       Date:  2018-08-01       Impact factor: 7.389

5.  Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5.

Authors:  Maria A Parker; Laura R Erker; Isabelle Audo; Dongseok Choi; Saddek Mohand-Said; Kastytis Sestakauskas; Patrick Benoit; Terence Appelqvist; Melissa Krahmer; Caroline Ségaut-Prévost; Brandon J Lujan; Ambar Faridi; Elvira N Chegarnov; Peter N Steinkamp; Cristy Ku; Mariana Matioli da Palma; Pierre-Olivier Barale; Sarah Ayelo-Scheer; Andreas Lauer; Tim Stout; David J Wilson; Richard G Weleber; Mark E Pennesi; José Alain Sahel; Paul Yang
Journal:  Am J Ophthalmol       Date:  2022-03-04       Impact factor: 5.488

6.  Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.

Authors:  Jacque L Duncan; Wendi Liang; Maureen G Maguire; Isabelle Audo; Allison R Ayala; David G Birch; Joseph Carroll; Janet K Cheetham; Simona Degli Esposti; Todd A Durham; Laura Erker; Sina Farsiu; Frederick L Ferris; Elise Heon; Robert B Hufnagel; Alessandro Iannaccone; Glenn J Jaffe; Christine N Kay; Michel Michaelides; Mark E Pennesi; José-Alain Sahel
Journal:  Am J Ophthalmol       Date:  2020-05-22       Impact factor: 5.488

7.  Test-Retest Variability of Functional and Structural Parameters in Patients with Stargardt Disease Participating in the SAR422459 Gene Therapy Trial.

Authors:  Maria A Parker; Dongseok Choi; Laura R Erker; Mark E Pennesi; Paul Yang; Elvira N Chegarnov; Peter N Steinkamp; Catherine L Schlechter; Claire-Marie Dhaenens; Saddek Mohand-Said; Isabelle Audo; Jose Sahel; Richard G Weleber; David J Wilson
Journal:  Transl Vis Sci Technol       Date:  2016-10-01       Impact factor: 3.283

8.  A Cross-Sectional and Longitudinal Study of Retinal Sensitivity in RPE65-Associated Leber Congenital Amaurosis.

Authors:  Neruban Kumaran; Gary S Rubin; Angelos Kalitzeos; Kaoru Fujinami; James W B Bainbridge; Richard G Weleber; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-07-02       Impact factor: 4.799

9.  Microperimetry Hill of Vision and Volumetric Measures of Retinal Sensitivity.

Authors:  Amandeep Singh Josan; Thomas M W Buckley; Laura J Wood; Jasleen K Jolly; Jasmina Cehajic-Kapetanovic; Robert E MacLaren
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

10.  Structure-Function Modeling of Optical Coherence Tomography and Standard Automated Perimetry in the Retina of Patients with Autosomal Dominant Retinitis Pigmentosa.

Authors:  Travis B Smith; Maria Parker; Peter N Steinkamp; Richard G Weleber; Ning Smith; David J Wilson
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.